World Library  
Flag as Inappropriate
Email this Article

Harald zur Hausen

Article Id: WHEBN0017608618
Reproduction Date:

Title: Harald zur Hausen  
Author: World Heritage Encyclopedia
Language: English
Subject: Nobel Prize in Physiology or Medicine, Luc Montagnier, Papillomavirus, Cervical cancer, 2008
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Harald zur Hausen

Harald zur Hausen
Born (1936-03-11) 11 March 1936
Gelsenkirchen, Province of Westphalia, Germany
Nationality German
Fields Virology
Institutions German Cancer Research Center University of Heidelberg
Known for Discovery that HPV can cause cervical cancer
Notable awards Ernst Jung Prize (1996)
Prince Mahidol Award (2005)
Nobel Prize in Physiology or Medicine (2008)

Harald zur Hausen (born 11 March 1936) is a German virologist and professor emeritus. He has done research on cancer of the cervix, where he discovered the role of papilloma viruses, for which he received the Nobel Prize in Physiology or Medicine 2008.

Biography

Zur Hausen was born in Gelsenkirchen, Germany, went to the Gymnasium in Vechta, and studied medicine at the Universities of Bonn, Hamburg and Düsseldorf and received a Doctor of Medicine degree in 1960 from the University of Düsseldorf, after which he became a medical assistant.

Two years later, he joined the Institute for Microbiology at the University of Düsseldorf as a laboratory assistant. After three and a half years, he moved to Philadelphia and worked at the Virus Laboratories of the Children's Hospital together with the famous husband and wife virologists, Werner and Gertrude Henle [1], who had to escape from Nazi Germany. In a ground-breaking study, he contributed to finding for the first time that a cancer virus (Epstein-Barr virus) can transform healthy cells (lymphocytes) into cancer cells [2]. This directly showed that viruses can cause cancer cell formation. He became an assistant professor at the University of Pennsylvania. In 1969, he became a regular teaching and researching professor at the University of Würzburg, where he worked at the Institute for Virology. In 1972, he moved to the University of Erlangen-Nuremberg. In 1977, he moved on to the University of Freiburg (Breisgau), where he headed the department of virology and hygiene. Working with Lutz Gissmann, zur Hausen first isolated human papillomavirus 6 by simple centrifugation from genital warts. Together with Ethel-Michele de Villiers, who would marry zur Hausen after his divorce from his first wife, this group isolated HPV 6 DNA from genital warts, suggesting a possible new way of identifying viruses in human tumors. This paid off several years later in 1983 when zur Hausen identified HPV 16 DNA in cervical cancer tumors by Southern blot hybridization [3]. This was followed by discovery of HPV18 a year later [4], thus identifying the culprits responsible for ~75% of human cervical cancer. This sparked a major scientific controversy with other scientists favoring herpes simplex as a cause for cervical cancer.

From 1983 until 2003 zur Hausen served as a chairman and member of the scientific advisory board of the Europe. It was founded by doctor Mildred Scheel, the late “First Lady” of Germany. Zur Hausen has three sons from his first wife.

Scientific merits

Zur Hausen's specific field of research is the study of oncoviruses. In 1976, he published the hypothesis that human papillomavirus plays an important role in the cause of cervical cancer. Together with his collaborators, he then identified HPV16 and HPV18 in cervical cancers in 1983-4. This research directly made possible the development of a vaccine which was introduced in 2006. See also HPV vaccine. He is also credited with discovery of the virus causing genital warts (HPV 6) and a monkey lymphotropic polyomavirus that is a close relative to a recently discovered human Merkel cell polyomavirus, as well as techniques to immortalize cells with Epstein-Barr virus and to induce replication of the virus using phorbol esters. His work on papillomaviruses and cervical cancer received a great deal of scientific criticism on initial unveiling but subsequently was confirmed and extended to other high-risk papillomaviruses.

He received the Gairdner Foundation International Award in 2008 for his contributions to medical science.[2] He also shared the 2008 Nobel Prize in Medicine with Luc Montagnier and Françoise Barré-Sinoussi, who discovered the human immunodeficiency virus.[3]

There was controversy over the 2008 Nobel when it was learned that Bo Angelin, a member of the Nobel Assembly that year, also sat on the board of AstraZeneca, a company which earns patent royalties for HPV vaccines.[4] This was exacerbated by the fact that AstraZeneca had also entered into a partnership with Nobel Web and Nobel Media to sponsor documentaries and lectures to increase awareness of the prize.[4] However, colleagues widely felt that the award was deserved,[5] and the secretary of the Nobel Committee and Assembly made a statement that at the time of the vote, Bo Angelin did not know of AstraZeneca's HPV vaccine patents.[4]

Books

  • Infections Causing Human Cancer (2006) (Print ISBN 978-3-527-31056-2; Online ISBN 978-3-527-60931-4)
  • Cornwall, Claudia M. Catching cancer : the quest for its viral and bacterial causes. Lanham: Rowman & Littlefield Publishers, 2013.

Awards

References

  1. ^ Nobel Laureates of the University of Heidelberg
  2. ^
  3. ^ 2008 Nobel Prize winner "for his discovery of human papilloma viruses causing cervical cancer"
  4. ^ a b c
  5. ^
  6. ^

External links

  • Zur Hausen Nobel Prize lecture
  • Hausen: CV, Interviews, Publications
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.